Fisher & Paykel Healthcare has provided guidance for the first half of the 2025 financial year, expecting revenue to be in the range of approximately $940 million to $950m, and net profit after tax in the range of approximately $150m to $160m.
This would represent 18% growth in reported operating revenue and 44% growth in reported net profit after tax, compared to the first half of the 2024 financial year.
The company also updated its full year outlook, maintaining its previous guidance for operating revenue to be around $1.9b to $2b.
However, it now expects full year net profit after tax to be in the range of approximately $320m to $370m.
Fisher & Paykel Healthcare's 2024 annual shareholders' meeting is scheduled for Aug 28.
See more
